Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes

Diabetologia

Volumn 55, Issue 5, 2012, Pages 1458-1468

  Maharaj, A ^a,b   Zhu, L ^a,b,c   Huang, F ^a,f   Qiu, H ^a,b   Li, H ^d   Zhang, C Y ^c   Jin, T ^d,e   Wang, Q ^a,b,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c NANJING UNIVERSITY   (China)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Diabetes; GCGR; Glucagon; Glucose; High fat diet; Insulin; Islet; Muscle

Indexed keywords

CREATINE KINASE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DECOY RECEPTOR 3; FRUCTOSE BISPHOSPHATASE; GLUCAGON; GLUCAGON RECEPTOR; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; CREATINE KINASE, MM FORM; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FRUCTOSE-BISPHOSPHATASE; GLUCAGON; GLUCOSE-6-PHOSPHATASE; INSULIN; INSULIN-SECRETING CELLS; LIVER; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUCAGON;

EID: 84862826524     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2464-x     Document Type: Article

References (50)

1. Bansal P, Wang Q (2008) Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 295: E751-E761
2. Jiang G, Zhang BB (2003) Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284: E671-E678
3. Gromada J, Franklin I, Wollheim CB (2007) Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28: 84-116
4. Gastaldelli A, Baldi S, Pettiti M et al (2000) Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49: 1367-1373
5. Sherwin RS, Fisher M, Hendler R, Felig P (1976) Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med 294: 455-461
6. Unger RH (1978) Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 27: 1691-1709
7. Li XC, Liao TD, Zhuo JL (2008) Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of type 2 diabetes in mice. Clin Sci (Lond) 114: 591-601
8. Rizza R, Verdonk C, Miles J, Service FJ, Gerich J (1979) Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. J Clin Invest 63: 1119-1123
9. Unger RH, Orci L (2010) Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A 107: 16009-16012
10. Gelling RW, Du XQ, Dichmann DS et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A 100: 1438-1443
11. Conarello SL, Jiang G, Mu J et al (2007) Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia 50: 142-150
12. Petersen KF, Sullivan JT (2001) Effects of a novel glucagons receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia 44: 2018-2024
13. Liang Y, Osborne MC, Monia BP et al (2004) Reduction in glucagons receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. Diabetes 53: 410-417
14. Gu W, Yan H, Winters KA et al (2009) Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia. J Pharmacol Exp Ther 331: 871-881
15. Yan H, Gu W, Yang J et al (2009) Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys. J Pharmacol Exp Ther 329: 102-111
16. Vuguin PM, Kedees MH, Cui L et al (2006) Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 147: 3995-4006
17. Schertzer JD, Antonescu CN, Bilan PJ et al (2009) A transgenic mouse model to study glucose transporter 4myc regulation in skeletal muscle. Endocrinology 150: 1935-1940
18. Hansen LH, Abrahamsen N, Nishimura E (1995) Glucagon receptor mRNA distribution in rat tissues. Peptides 16: 1163-1166
19. Burcelin R, Li J, Charron MJ (1995) Cloning and sequence analysis of the murine glucagon receptor-encoding gene. Gene 164: 305-310
20. Soltani N, Kumar M, Glinka Y, Prud'homme GJ, Wang Q (2007) In vivo expression of GLP-1/IgG-Fc fusion protein enhances betacell mass and protects against streptozotocin-induced diabetes. Gene Ther 14: 981-988
21. Wang Q, Khayat Z, Kishi K, Ebina Y, Klip A (1998) GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay. FEBS Lett 427: 193-197
22. Jin T, Drucker DJ (1995) The proglucagon gene upstream enhancer contains positive and negative domains important for tissue-specific proglucagon gene transcription. Mol Endocrinol 9: 1306-1320
23. Wang Q, Somwar R, Bilan PJ et al (1999) Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 19: 4008-4018
24. Unson CG, Cypess AM, Kim HN et al (1995) Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding. J Biol Chem 270: 27720-27727
25. Zhang N, Kumar M, Xu G et al (2006) Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines. Diabetologia 49: 506-518
26. Wang Q, Brubaker PL (2002) Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 45: 1263-1273
27. Kim SJ, Nian C, Widenmaier S, McIntosh CH (2008) Glucosedependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMPresponsive CREB coactivator 2. Mol Cell Biol 28: 1644-1656
28. Jhala US, Canettieri G, Screaton RA et al (2003) cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17: 1575-1580
29. Balage M, Grizard J (1986) Relationship between plasma glucagons disappearance and tissue uptake in rats. Reprod Nutr Dev 26: 31-38
30. Kuwajima M, Golden S, Katz J, Unger RH, Foster DW, McGarry JD (1986) Active hepatic glycogen synthesis from gluconeogenic precursors despite high tissue levels of fructose 2, 6-bisphosphate. J Biol Chem 261: 2632-2637
31. Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57: 3169-3176
32. Huypens P, Ling Z, Pipeleers D, Schuit F (2000) Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 43: 1012-1019
33. Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K (1995) Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia 38: 274-276
34. Sorensen H, Winzell MS, Brand CL et al (2006) Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function. Diabetes 55: 3463-3469
35. Gelling RW, Vuguin PM, Du XQ et al (2009) Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass. Am J Physiol Endocrinol Metab 297: E695-E707
36. Xu E, Kumar M, Zhang Yet al (2006) Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab 3: 47-58
37. Tsuchiyama N, Takamura T, Ando H et al (2007) Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes. Diabetes Care 30: 2583-2587
38. Dalle S, Longuet C, Costes S et al (2004) Glucagon promotes cAMP-response element-binding protein phosphorylation via activation of ERK1/2 in MIN6 cell line and isolated islets of Langerhans. J Biol Chem 279: 20345-20355
39. Aspinwall CA, Lakey JR, Kennedy RT (1999) Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem 274: 6360-6365
40. Wang Q, Jin T (2009) The role of insulin signaling in the development of beta-cell dysfunction and diabetes. Islets 1: 95-101
41. Johnson JD, Bernal-Mizrachi E, Alejandro EU et al (2006) Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci U S A 103: 19575-19580
42. Paraskevas S, Aikin R, Maysinger D et al (2001) Modulation of JNK and p38 stress activated protein kinases in isolated islets of Langerhans: insulin as an autocrine survival signal. Ann Surg 233: 124-133
43. Jetton TL, Lausier J, LaRock K et al (2005) Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 54: 2294-2304
44. Maeda H, Rajesh KG, Maeda H, Suzuki R, Sasaguri S (2004) Epidermal growth factor and insulin inhibit cell death in pancreatic beta cells by activation of PI3-kinase/AKT signaling pathway under oxidative stress. Transplant Proc 36: 1163-1165
45. Zhao J, Zhang N, He M et al (2008) Increased beta-cell apoptosis and impaired insulin signaling pathway contributes to the onset of diabetes in OLETF rats. Cell Physiol Biochem 21: 445-454
46. Peltier J, O'Neill A, Schaffer DV (2007) PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 67: 1348-1361
47. Ramnanan CJ, Edgerton DS, Kraft G, Cherrington AD (2011) Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab 13(Suppl 1): S118-S125
48. Rivera N, Ramnanan CJ, An Z et al (2010) Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs. J Clin Invest 120: 4425-4435
49. Taniguchi CM, Tran TT, Kondo T et al (2006) Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proc Natl Acad Sci U S A 103: 12093-12097
50. Fisher SJ, Kahn CR (2003) Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest 111: 463-468